E15 VC
Overview
E15 VC is a venture capital firm based in Hong Kong that focuses on education, healthcare and technology-related companies across Hong Kong and the United States . The firm invests in companies operating in the information technology sectors .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Eikon Therapeutics | Feb 2025 | Series D | Co-investor |
| SAM Labs | Nov 2017 | Series A | Lead |
| Fluent Metal | Mar 2024 | Seed | Lead |
| Caeli Vascular, Inc. | Jul 2023 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is E15 VC based?
E15 VC is headquartered in Hong Kong.
When was E15 VC founded?
E15 VC was founded in 2017.
How many portfolio companies does E15 VC have?
E15 VC has 4 portfolio companies in Caplight's dataset.
What are some companies in E15 VC's portfolio?
Portfolio companies visible on Caplight include Eikon Therapeutics, SAM Labs, Fluent Metal, Caeli Vascular, Inc..
What was E15 VC's most recent investment shown here?
E15 VC's most recent investment in this portfolio sample was in Eikon Therapeutics in 2025.
What sectors does E15 VC focus on?
E15 VC focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software.
What company stages does E15 VC focus on?
E15 VC typically invests at the Early stage.
What is E15 VC's AUM?
E15 VC's assets under management are estimated between $100.0M and $250.0M.